Stock

Paychex beat earnings expectations by 10% but the price is overvalued

Paychex Inc. (NASDAQ:PAYX) beat Q3-2022 earnings expectations by 10%. The performance reflected strong growth in revenues and income. The share price gained 6.36%, from $128 to $136 on the announcement. While the price movement is a great reflection of the performance, investors need to study the price a little more closely.

Paychex is trading at a price of $136.89, a day after the announcement. The valuation is on the upper side of the year range of $92.74 – $138.97. The price level is also at a key resistance level, leading to the question of what to expect with the price movements.

The stock has a PEG ratio of 5.02, indicating that it is certainly overvalued. It scores D on value and growth indicators, with an F-score on momentum. Despite beating expectations, the scores indicate that there is nothing fundamentally so critical as to take the stock price higher.

Paychex at a key resistance level of $136

Source – TradingView

From a technical perspective, Paychex appears to have picked bullish momentum on the MACD. The RSI 65.74 tends towards the overbought region. Historically, Paychex trades very close to RSI 70 often and for several weeks at a time. For the investor, this means that holding the stock until it hits the levels may not be a bad idea. Zacks ranks Paychex as a hold. What this analysis would like to emphasize is that buying Paychex at the current highs may not be a good idea.

Summary

Paychex beat earnings expectations for Q3 by 10%. The price is trading at a historically high price and an important resistance level with weak signs of a breakout. Holding the stock is advisable, but buying is not.

The post Paychex beat earnings expectations by 10% but the price is overvalued appeared first on Invezz.

Disclaimer: MonopolyWinnersUpdates.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 MonopolyWinnersUpdates.com. All Rights Reserved.

To Top